Browsing "1. Journal Papers" by Identifier : 0923-7534

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 14 of 14

This table browses all dspace content
Issue DateTitleJournal Title
2013A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesANNALS OF ONCOLOGY
2004A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer ANNALS OF ONCOLOGY
2022Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with 쎼ANNALS OF ONCOLOGY
2011Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. ANNALS OF ONCOLOGY
2022Assessment of high Ki67 (≥20%) ER+HER2- breast cancer with a 21-gene multigene assayANNALS OF ONCOLOGY
2013Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer ANNALS OF ONCOLOGY
2010Expression of androgen receptors in primary breast cancer ANNALS OF ONCOLOGY
2007Health-related quality of life in disease-free survivors of breast cancer with the general population ANNALS OF ONCOLOGY
2013Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) ANNALS OF ONCOLOGY
2008Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer ANNALS OF ONCOLOGY
2008Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up. ANNALS OF ONCOLOGY
2008Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes ANNALS OF ONCOLOGY
2022Randomized phase II trial of upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy versus preoperative chemoradiotherapy followed by surgery and adjuvant chemotherapy in locally advanced rectal cancer: KCSG-CO14-10ANNALS OF ONCOLOGY
2008Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases ANNALS OF ONCOLOGY
1

Browse

Links